| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/01/2004 | US20040063674 Tetracycline compounds having target therapeutic activities |
| 04/01/2004 | US20040063670 Use of bisphosphonates for pain treatment |
| 04/01/2004 | US20040063661 Treatment of statin side effects |
| 04/01/2004 | US20040063647 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 04/01/2004 | US20040063646 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 04/01/2004 | US20040063644 Urea and urethane derivatives as integrin inhibitors |
| 04/01/2004 | US20040063641 Healing fractures in distractive osteogenesis; accelerating regeneration and consolidation; torsional and mechanical stiffness; mass |
| 04/01/2004 | US20040063629 Treatment of damaged connective tissue |
| 04/01/2004 | US20040062820 Administering blend of calcium compound and fat; reducing osteoporosis |
| 04/01/2004 | US20040062818 Composition of hypochlorous acid and its applications |
| 04/01/2004 | CA2499964A1 Methods and compositions of novel triazine compounds |
| 04/01/2004 | CA2498662A1 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | CA2497903A1 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient |
| 03/31/2004 | EP1403284A1 HAb18G/CD147, IT'S AGONIST AND APPLICATION |
| 03/31/2004 | EP1403270A1 Pde iv inhibitors |
| 03/31/2004 | EP1403266A1 Process for the industrial synthesis of strontium ranelate and hydrates thereof |
| 03/31/2004 | EP1403255A1 Rho KINASE INHIBITORS |
| 03/31/2004 | EP1402888A1 The use of substituted carbocyclic compounds as rotamases inhibitors |
| 03/31/2004 | EP1402066A2 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
| 03/31/2004 | EP1402054A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 03/31/2004 | EP1402028A2 Oligonucleotides for regulating the gene coding for tnf-alpha and/or genes controlled thereby and use thereof |
| 03/31/2004 | EP1401999A2 B7 related protein-2 molecules and uses thereof |
| 03/31/2004 | EP1401870A2 Antibodies against tumor necrosis factor delta (april) |
| 03/31/2004 | EP1401863A1 Somatostatin-dopamine chimeric analogs |
| 03/31/2004 | EP1401862A2 Peptide compounds for counteracting reactive oxygen species and free radicals |
| 03/31/2004 | EP1401840A1 Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines |
| 03/31/2004 | EP1401835A1 Carboline derivatives as pde-5 inhibitors |
| 03/31/2004 | EP1401822A1 Naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 03/31/2004 | EP1401818A2 Targeted multivalent macromolecules |
| 03/31/2004 | EP1401801A1 Selective androgen receptor modulators and methods of use thereof |
| 03/31/2004 | EP1401506A2 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy |
| 03/31/2004 | EP1401498A1 Anti-ngf antibodies for the treatment of various disorders |
| 03/31/2004 | EP1401485A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3 4-(2- 4-methane sulfonyl oxyphenyl ethoxy)phenyl] propanoic acid or 3- 4- 2- (4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl -(s)-2-ethoxy propanoic acid and insulin |
| 03/31/2004 | EP1401481A1 Mucosal repair by tff dimer peptides |
| 03/31/2004 | EP1401472A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 03/31/2004 | EP1401467A1 Alpha-fetoprotein peptides and uses thereof |
| 03/31/2004 | EP1401461A2 Selective cox-2 inhibition from edible plant extracts |
| 03/31/2004 | EP1401460A2 Selective cox-2 inhibition from plant extracts |
| 03/31/2004 | EP1401455A1 Use of a phosphate adsorbent to combat vascular diseases |
| 03/31/2004 | EP1401453A2 Protease inhibitors |
| 03/31/2004 | EP1401451A2 Quinazoline derivatives which promote the release of parathyroid hormone |
| 03/31/2004 | EP1401449A1 Tetracyclic compounds as pde5-inhibitors |
| 03/31/2004 | EP1401448A1 Antibacterial treatment of osteoarthritis |
| 03/31/2004 | EP1401446A1 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen |
| 03/31/2004 | EP1401433A2 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method |
| 03/31/2004 | EP1401420A2 Perturbed membrane-binding compounds |
| 03/31/2004 | EP1401415A2 Use of tyrosine kinase inhibitors for treating inflammatory diseases |
| 03/31/2004 | EP1401411A2 Use of tyrosine kinase inhibitors for treating bone loss |
| 03/31/2004 | EP1401410A2 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 03/31/2004 | EP1401406A2 Delivery of a bioactive material |
| 03/31/2004 | EP1401375A2 Methods for inhibiting macrophage colony stimulating factor and c-fms-dependent cell signaling |
| 03/31/2004 | EP1401269A2 Transgenic animal model of bone mass modulation |
| 03/31/2004 | EP1232174A4 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 03/31/2004 | EP1232144B1 Novel il-8 receptor antagonists |
| 03/31/2004 | EP1218026B1 Preparation of a medicament to enhance healing of the sternum after sternotomy |
| 03/31/2004 | EP1121349B1 Substituted thiadiazolsulfonamides used as interleukin-1-beta inhibitors |
| 03/31/2004 | EP1025098B1 Benzothiophenes |
| 03/31/2004 | EP1015421B1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
| 03/31/2004 | EP0871439B1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
| 03/31/2004 | EP0784677B1 Inhibitor of stem cell proliferation and uses thereof |
| 03/31/2004 | EP0777484B1 Intravenous alendronate formulations |
| 03/31/2004 | CN1486312A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486311A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486310A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486194A Colorstrum-based composition |
| 03/31/2004 | CN1486190A Compositions containing an active fraction isolated from scutellariae barbatae and methods of use |
| 03/31/2004 | CN1485086A Peroral Chinese medicine powder for treating bone fracture and its preparing process |
| 03/31/2004 | CN1485079A Chinese medicine combination for treating femur head necrosis |
| 03/31/2004 | CN1485075A Lotion for treating hyperosteogeny |
| 03/31/2004 | CN1485073A Medicine for treating hyperosteogeny and its preparation method |
| 03/31/2004 | CN1485070A Injection for curing rheumatism and rheumatoid and preparation process thereof |
| 03/31/2004 | CN1485068A Paster of external use for lumbocrural pain |
| 03/31/2004 | CN1485066A Powder of setting a broken bone for tumble and hit trauma |
| 03/31/2004 | CN1485063A Chinese traditional medicine formulation for rheumatism and its orthopaedic disease |
| 03/31/2004 | CN1485055A Rheumatism and rheumatoid disease medication of external use |
| 03/31/2004 | CN1143687C Plaster for treating cervical vertebra hyperplasia |
| 03/31/2004 | CN1143683C Exterior-applied black plaster for treating bone diseases and its preparing process |
| 03/30/2004 | US6713515 Administering benzyl, naphthyl acid derivatives |
| 03/30/2004 | US6713513 Method for treating cartilage related diseases |
| 03/30/2004 | US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 03/30/2004 | US6713482 Such as (e)-1-(2-pyridyl)-2-styryl-1h-benzimidazole; antiinflammatory and analgesic agents; prostaglandin inhibitors |
| 03/30/2004 | US6713452 Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 03/25/2004 | WO2004024758A1 Parathyroid hormone-like polypeptides |
| 03/25/2004 | WO2004024717A1 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 03/25/2004 | WO2004024697A1 Amine compounds and use thereof |
| 03/25/2004 | WO2004024694A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 03/25/2004 | WO2004024676A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| 03/25/2004 | WO2004024673A1 Amino-propanol derivatives |
| 03/25/2004 | WO2004024166A1 Method for preventing or reducing secondary fractures after hip fracture |
| 03/25/2004 | WO2004024060A2 Metalloproteinase inhibitors and intermediates for preparation thereof |
| 03/25/2004 | WO2004013138A3 Imidazo`1,2-a!pyridines |
| 03/25/2004 | WO2004013134A3 Compounds |
| 03/25/2004 | WO2004004665A3 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 03/25/2004 | WO2003105752A3 Methods and compositions for stimulating bone growth using nitric oxide releasing bisphosphonate conjugates (no-bisphosphonate) |
| 03/25/2004 | WO2003103681A3 Use of orally-available prostacyclin derivatives for the production of a medicament for the treatment of disease states associated with bone marrow oedema |
| 03/25/2004 | WO2003093314A3 Connective tissue stimulating peptides |
| 03/25/2004 | WO2003086326A3 G-type peptides to ameliorate atherosclerosis |
| 03/25/2004 | WO2003084941A3 Hydroxamic acid derivatives |
| 03/25/2004 | WO2003082271A3 Indole derivatives having anti-angiogenetic activity |
| 03/25/2004 | WO2003080070A3 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer |